Improving Adherence to Home Blood Pressure Monitoring With Pharmacist Support
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT04577131|
Recruitment Status : Terminated (The tracker application has been withdrawn by developer and no other suitable tracker application has been identified to replace it.)
First Posted : October 6, 2020
Last Update Posted : January 15, 2021
|Condition or disease||Intervention/treatment||Phase|
|Hypertension||Behavioral: Weekly check-in||Not Applicable|
High blood pressure is very common and increases risk of heart, kidney, brain, and eye disease. It is important to diagnose and treat high blood pressure to reduce risk of these complications. Getting blood pressure checked only when someone sees a doctor is not the best way to diagnose high blood pressure or to make sure blood pressure is well managed. Checking blood pressure at home gives a better idea of whether someone's blood pressure is normal or too high.
As part of their usual blood pressure monitoring, participants will be given an Omron 3 series or 5 series blood pressure monitor which has been cleared by the US Food and Drug Administration and validated to meet accuracy and performance requirements. For one month, participants will monitor their blood pressure once a day and then return the device to the clinic at the end of the study. Participants will text their blood pressure result to the American Heart Association's Check, Change, Control (CCC) secure online tracker.
As part of the research study, participants will also be randomized to either receive or not receive weekly check-in phone calls from a pharmacist to review their blood pressures and the number of times they tested in that week. Approximately 50 individuals will participate in this study. Participation in this study will last 1 month.
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||1 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Primary Purpose:||Supportive Care|
|Official Title:||Improving Adherence to Home Blood Pressure Monitoring With Pharmacist Support|
|Actual Study Start Date :||November 5, 2020|
|Actual Primary Completion Date :||November 5, 2020|
|Actual Study Completion Date :||November 5, 2020|
Experimental: With check-ins
Daily blood pressure monitoring with weekly check-ins
Behavioral: Weekly check-in
Weekly check-in phone calls from a pharmacist to review blood pressures and the number of times tested in that week
No Intervention: Without check-ins
Daily blood pressure monitoring without weekly check-ins
- Change in adherence to home blood pressure monitoring [ Time Frame: 1 month ]Proportion of days blood pressure is measured based on data from the blood pressuring monitor
- Change in proportion of participants with a blood pressure <130/80 mm Hg. [ Time Frame: 1 month ]Proportion of participants with a blood pressure <130/80 mm Hg.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04577131
|United States, Virginia|
|Virginia Commonwealth University|
|Richmond, Virginia, United States, 23298|
|Principal Investigator:||Dave Dixon, PharmD||Virginia Commonwealth University|